Abstract
Introduction: Primary pancreatic lymphoma is a rare clinical entity representing <0.5% of pancreatic cancers and 1% of extranodal lymphomas. Due to the lack of evidence of cases in the literature, their clinicopathological features, differential diagnosis, optimal therapy, and outcomes should be better defined.
We will present a case of a 41-year-old woman who presented symptoms such as nausea, epigastric pain, red blood vomiting, and melena.
At laparotomy, a large necrotic mass was found in the body and tail of the pancreas, infiltrating the stomach and spleen. A biopsy of the mass confirmed large B-cell lymphoma. The patient was diagnosed and started chemotherapy.
Conclusion: Primary pancreatic lymphoma is a rare clinical entity often misdiagnosed as pancreatic adenocarcinoma on presentation. Its clinical manifestations, radiological features, and biochemical signs are usually non-specific. It is based on a precise diagnosis made possible by histologic examination. Combined therapy remains the most optimal treatment approach for PPL but needs further evaluation.
References
2. Mishra, M. V., Keith, S. W., Shen, X., Bar Ad, V., Champ, C. E., & Biswas, T. (2013). Primary pancreatic lymphoma: a population-based analysis using the SEER program. American journal of clinical oncology, 36(1), 38–43. https://doi.org/10.1097/COC.0b013e3182354bbb
3. Haji, A. G., Sharma, S., Majeed, K. A., Vijaykumar, D. K., Pavithran, K., & Dinesh, M. (2009). Primary pancreatic lymphoma: Report of three cases with review of the literature. Indian journal of medical and pediatric oncology: official journal of Indian Society of Medical & Paediatric Oncology, 30(1), 20–23. https://doi.org/10.4103/0971-5851.56331
4. Facchinelli, D., Boninsegna, E., Visco, C., & Tecchio, C. (2021). Primary Pancreatic Lymphoma: Recommendations for Diagnosis and Management. Journal of blood medicine, 12, 257–267. https://doi.org/10.2147/JBM.S273095
5. Nishimura, R., Takakuwa, T., Hoshida, Y., Tsujimoto, M., & Aozasa, K. (2001). Primary pancreatic lymphoma: clinicopathological analysis of 19 cases from Japan and review of the literature. Oncology, 60(4), 322–329. https://doi.org/10.1159/000058528
6. Zhu, N. X., Wang, X. Y., Tong, T., Xu, J. H., Yang, Y. Y., & Tian, L. (2022). Primary pancreatic lymphoma diagnosed by endoscopic ultrasound-guided fine needle biopsy. Hepatobiliary & pancreatic diseases international: HBPD INT, 21(1), 99–102. https://doi.org/10.1016/j.hbpd.2021.05.001
7. Gök, A. F. K., Sönmez, R. E., Kantarcı, T. R., Bayraktar, A., Emiroğlu, S., İlhan, M., & Güloğlu, R. (2019). Discussing treatment strategies for acute mechanical intestinal obstruction caused by phytobezoar: A single-center retrospective study. Fitobezoara bağlı akut mekanik intestinal obstrüksiyon için tedavi stratejilerinin tartışılması: Tek merkezli geriye dönük bir çalışma. Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 25(5), 503–509. https://doi.org/10.14744/tjtes.2019.24557
8. Sapkota S, Shaikh H. Non-Hodgkin Lymphoma. [Updated 2023 Feb 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559328/
9. DAWSON, I. M., CORNES, J. S., & MORSON, B. C. (1961). Primary malignant lymphoid tumors of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. The British Journal of Surgery, pp. 49, 80–89. https://doi.org/10.1002/bjs.18004921319
10. Wallace, D., Dang, N., Dhawan, M., & Kulkarni, A. (2012). Diagnosis of a patient with primary pancreatic lymphoma. Gastroenterology & hepatology, 8(12), 850–852.
11. Ballehaninna, U. K., & Chamberlain, R. S. (2012). The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. Journal of Gastrointestinal Oncology, 3(2), 105–119. https://doi.org/10.3978/j.issn.2078-6891.2011.021
12. Poruk, K. E., Gay, D. Z., Brown, K., Mulvihill, J. D., Boucher, K. M., Scaife, C. L., Firpo, M. A., & Mulvihill, S. J. (2013). The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Current molecular medicine, 13(3), 340–351. https://doi.org/10.2174/1566524011313030003
13. Chen, W., Luo, R. C., Fan, W. W., & Ma, S. D. (2006). Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 26(2), 227–230.
14. Merkle, E. M., Bender, G. N., & Brambs, H. J. (2000). Imaging findings in pancreatic lymphoma: differential aspects. AJR. American Journal of roentgenology, 174(3), 671–675. https://doi.org/10.2214/ajr.174.3.1740671
15. Rose, J. F., Jie, T., Usera, P., & Ong, E. S. (2012). Pancreaticoduodenectomy for primary pancreatic lymphoma. Gastrointestinal cancer research: GCR, 5(1), 32–34.
16. Nakaoka K, Ohno E, Kawabe N, Kuzuya T, Funasaka K, Nakagawa Y, Nagasaka M, Ishikawa T, Watanabe A, Tochio T, et al. Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma. Diagnostics. 2023; 13(2):215. https://doi.org/10.3390/diagnostics13020215
17. Boninsegna, E., Zamboni, G.A., Facchinelli, D. et al. CT imaging of primary pancreatic lymphoma: experience from three referral centers for pancreatic diseases. Insights Imaging 9, 17–24 (2018). https://doi.org/10.1007/s13244-017-0585-y
18. Salvatore, J. R., Cooper, B., Shah, I., & Kummet, T. (2000). Primary pancreatic lymphoma: a case report, literature review, and proposal for nomenclature. Medical oncology (Northwood, London, England), 17(3), 237–247. https://doi.org/10.1007/BF02780536
19. Yu, L., Chen, Y., & Xing, L. (2017). Primary pancreatic lymphoma: two case reports and a literature review. OncoTargets and therapy, 10, 1687–1694. https://doi.org/10.2147/OTT.S121521
20. Behrns, K. E., Sarr, M. G., & Strickler, J. G. (1994). Pancreatic lymphoma: Is it a surgical disease? Pancreas, 9(5), 662–667.
21. Grimison, P. S., Chin, M. T., Harrison, M. L., & Goldstein, D. (2006). Primary pancreatic lymphoma--pancreatic tumors that are potentially curable without resection, a retrospective review of four cases. BMC cancer, 6, 117. https://doi.org/10.1186/1471-2407-6-117
22. Hiddemann, W., Kneba, M., Dreyling, M., Schmitz, N., Lengfelder, E., Schmits, R., Reiser, M., Metzner, B., Harder, H., Hegewisch-Becker, S., Fischer, T., Kropff, M., Reis, H. E., Freund, M., Wörmann, B., Fuchs, R., Planker, M., Schimke, J., Eimermacher, H., Trümper, L., … Unterhalt, M. (2005). Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood, 106(12), 3725–3732. https://doi.org/10.1182/blood-2005-01-0016
23. Tuchek, J. M., De Jong, S. A., & Pickleman, J. (1993). Diagnosis, surgical intervention, and prognosis of primary pancreatic lymphoma. The American Surgeon, 59(8), 513–518.
24. Liakakos, T., Misiakos, E. P., Tsapralis, D., Nikolaou, I., Karatzas, G., & Macheras, A. (2008). A role for surgery in primary pancreatic B-cell lymphoma: a case report. Journal of Medical Case Reports, 2, 167. https://doi.org/10.1186/1752-1947-2-167
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.